591 related articles for article (PubMed ID: 27426932)
21. The impact of macular pigment augmentation on visual performance using different carotenoid formulations.
Loughman J; Nolan JM; Howard AN; Connolly E; Meagher K; Beatty S
Invest Ophthalmol Vis Sci; 2012 Nov; 53(12):7871-80. PubMed ID: 23132800
[TBL] [Abstract][Full Text] [Related]
22. Plasma long-chain omega-3 polyunsaturated fatty acids and macular pigment in subjects with family history of age-related macular degeneration: the Limpia Study.
Merle BMJ; Buaud B; Korobelnik JF; Bron A; Delyfer MN; Rougier MB; Savel H; Vaysse C; Creuzot-Garcher C; Delcourt C
Acta Ophthalmol; 2017 Dec; 95(8):e763-e769. PubMed ID: 28271618
[TBL] [Abstract][Full Text] [Related]
23. Supplemental Retinal Carotenoids Enhance Memory in Healthy Individuals with Low Levels of Macular Pigment in A Randomized, Double-Blind, Placebo-Controlled Clinical Trial.
Power R; Coen RF; Beatty S; Mulcahy R; Moran R; Stack J; Howard AN; Nolan JM
J Alzheimers Dis; 2018; 61(3):947-961. PubMed ID: 29332050
[TBL] [Abstract][Full Text] [Related]
24. Supplementation with macular carotenoids reduces psychological stress, serum cortisol, and sub-optimal symptoms of physical and emotional health in young adults.
Stringham NT; Holmes PV; Stringham JM
Nutr Neurosci; 2018 May; 21(4):286-296. PubMed ID: 28198205
[TBL] [Abstract][Full Text] [Related]
25. Fluorescence lifetime imaging ophthalmoscopy and the influence of oral lutein/zeaxanthin supplementation on macular pigment (FLOS) - A pilot study.
Jaggi D; Solberg Y; Dysli C; Lincke J; Habra O; Wyss A; Wolf S; Zinkernagel M
Clin Nutr ESPEN; 2023 Aug; 56():127-134. PubMed ID: 37344061
[TBL] [Abstract][Full Text] [Related]
26. Supplementation with three different macular carotenoid formulations in patients with early age-related macular degeneration.
Sabour-Pickett S; Beatty S; Connolly E; Loughman J; Stack J; Howard A; Klein R; Klein BE; Meuer SM; Myers CE; Akuffo KO; Nolan JM
Retina; 2014 Sep; 34(9):1757-66. PubMed ID: 24887490
[TBL] [Abstract][Full Text] [Related]
27. Effect of supplemental lutein and zeaxanthin on serum, macular pigmentation, and visual performance in patients with early age-related macular degeneration.
Huang YM; Dou HL; Huang FF; Xu XR; Zou ZY; Lin XM
Biomed Res Int; 2015; 2015():564738. PubMed ID: 25815324
[TBL] [Abstract][Full Text] [Related]
28. The heritability of macular response to supplemental lutein and zeaxanthin: a classic twin study.
Hammond CJ; Liew SH; Van Kuijk FJ; Beatty S; Nolan JM; Spector TD; Gilbert CE
Invest Ophthalmol Vis Sci; 2012 Jul; 53(8):4963-8. PubMed ID: 22700713
[TBL] [Abstract][Full Text] [Related]
29. Macular carotenoid supplementation in subjects with atypical spatial profiles of macular pigment.
Nolan JM; Akkali MC; Loughman J; Howard AN; Beatty S
Exp Eye Res; 2012 Aug; 101():9-15. PubMed ID: 22652506
[TBL] [Abstract][Full Text] [Related]
30. LAST II: Differential temporal responses of macular pigment optical density in patients with atrophic age-related macular degeneration to dietary supplementation with xanthophylls.
Richer S; Devenport J; Lang JC
Optometry; 2007 May; 78(5):213-9. PubMed ID: 17478338
[TBL] [Abstract][Full Text] [Related]
31. Visual Function and Macular Carotenoid Changes in Eyes with Retinal Drusen-An Open Label Randomized Controlled Trial to Compare a Micronized Lipid-Based Carotenoid Liquid Supplementation and AREDS-2 Formula.
Davey PG; Henderson T; Lem DW; Weis R; Amonoo-Monney S; Evans DW
Nutrients; 2020 Oct; 12(11):. PubMed ID: 33114566
[TBL] [Abstract][Full Text] [Related]
32. The impact of supplemental macular carotenoids in Alzheimer's disease: a randomized clinical trial.
Nolan JM; Loskutova E; Howard A; Mulcahy R; Moran R; Stack J; Bolger M; Coen RF; Dennison J; Akuffo KO; Owens N; Power R; Thurnham D; Beatty S
J Alzheimers Dis; 2015; 44(4):1157-69. PubMed ID: 25408222
[TBL] [Abstract][Full Text] [Related]
33. Cognitive Function and Its Relationship with Macular Pigment Optical Density and Serum Concentrations of its Constituent Carotenoids.
Kelly D; Coen RF; Akuffo KO; Beatty S; Dennison J; Moran R; Stack J; Howard AN; Mulcahy R; Nolan JM
J Alzheimers Dis; 2015; 48(1):261-77. PubMed ID: 26401946
[TBL] [Abstract][Full Text] [Related]
34. Lutein supplementation over a one-year period in early AMD might have a mild beneficial effect on visual acuity: the CLEAR study.
Murray IJ; Makridaki M; van der Veen RL; Carden D; Parry NR; Berendschot TT
Invest Ophthalmol Vis Sci; 2013 Mar; 54(3):1781-8. PubMed ID: 23385792
[TBL] [Abstract][Full Text] [Related]
35. Serum and Macular Carotenoids in Relation to Retinal Vessel Caliber Fifteen Years Later, in the Second Carotenoids in Age-Related Eye Disease Study.
Lawler T; Korger J; Liu Y; Liu Z; Pak JW; Barrett N; Blodi B; Domalpally A; Johnson E; Wallace R; Mares JA;
Invest Ophthalmol Vis Sci; 2021 Jul; 62(9):20. PubMed ID: 34254974
[TBL] [Abstract][Full Text] [Related]
36. Association of macular pigment optical density with serum concentration of oxidized low-density lipoprotein in healthy adults.
Nagai N; Izumi-Nagai K; Suzuki M; Shinoda H; Koto T; Uchida A; Mochimaru H; Tomita Y; Miyake S; Kobayashi S; Sasaki M; Tsubota K; Ozawa Y
Retina; 2015 Apr; 35(4):820-6. PubMed ID: 25473786
[TBL] [Abstract][Full Text] [Related]
37. The effect of nutritional supplementation on the multifocal electroretinogram in healthy eyes.
Berrow EJ; Bartlett HE; Eperjesi F
Doc Ophthalmol; 2016 Apr; 132(2):123-35. PubMed ID: 26988845
[TBL] [Abstract][Full Text] [Related]
38. The relationships between macular pigment optical density and its constituent carotenoids in diet and serum.
Nolan JM; Stack J; O'connell E; Beatty S
Invest Ophthalmol Vis Sci; 2007 Feb; 48(2):571-82. PubMed ID: 17251452
[TBL] [Abstract][Full Text] [Related]
39. Macular carotenoid supplementation improves disability glare performance and dynamics of photostress recovery.
Stringham JM; O'Brien KJ; Stringham NT
Eye Vis (Lond); 2016; 3():30. PubMed ID: 27857944
[TBL] [Abstract][Full Text] [Related]
40. Macular pigment imaging in AREDS2 participants: an ancillary study of AREDS2 subjects enrolled at the Moran Eye Center.
Bernstein PS; Ahmed F; Liu A; Allman S; Sheng X; Sharifzadeh M; Ermakov I; Gellermann W
Invest Ophthalmol Vis Sci; 2012 Sep; 53(10):6178-86. PubMed ID: 22879423
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
